Properties (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:affiliatedWith |
gptkb:ABC_Research_Center
|
| gptkbp:built |
formulation issues
|
| gptkbp:campusFacilities |
gptkb:XYZ_University
|
| gptkbp:chemicalFormula |
thiazole derivatives
high melting point meets safety standards stable at room temperature reacts with amines interacts with proteins contains a thiazole ring conducted using NMR C12H15N3O2 |
| gptkbp:clinicalTrials |
Phase I
|
| gptkbp:collaborations |
with pharmaceutical companies
with international research teams |
| gptkbp:compatibleWith |
exhibits anti-inflammatory properties
|
| gptkbp:competitors |
high potential
|
| gptkbp:composedOf |
via multi-step organic synthesis
|
| gptkbp:dissolved |
soluble in DMSO
|
| gptkbp:drugInterdiction |
applied for
|
| gptkbp:fauna |
used in rat studies
|
| gptkbp:financial_aid |
stable under normal conditions
|
| gptkbp:formulation |
tablet form
|
| gptkbp:funding |
government grants
|
| gptkbp:future_plans |
develop new therapies
preclinical trials clinical trials planned |
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-923
|
| gptkbp:impact |
mild nausea
|
| gptkbp:is_aimed_at |
neurodegenerative disorders
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:judgingCriteria |
HPLC
|
| gptkbp:market |
not yet available
|
| gptkbp:notableWork |
significant in neuroscience
|
| gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)thiazol-2-yl)phenyl)acetamide
|
| gptkbp:patentAssignee |
gptkb:XYZ_Pharmaceuticals
|
| gptkbp:patentStatus |
patented
|
| gptkbp:publications |
published_in_Journal_of_Medicinal_Chemistry
|
| gptkbp:related_to |
WPC-922
|
| gptkbp:releaseYear |
2020
|
| gptkbp:research_focus |
neurological applications
|
| gptkbp:researchAndDevelopment |
promising results
|
| gptkbp:researchContribution |
completed
|
| gptkbp:route |
oral
|
| gptkbp:safety_features |
under investigation
|
| gptkbp:safetyFeatures |
ongoing
|
| gptkbp:scientificName |
performed in vitro
|
| gptkbp:targets |
neurotransmitter receptors
specific receptors in the brain |
| gptkbp:triggerType |
inhibits specific enzymes
|
| gptkbp:uses |
research in pharmacology
|
| gptkbp:weight |
233.27 g/mol
|